Host antitumor immune responses to HIFU ablation

International Journal of Hyperthermia

Volumn 23, Issue 2, 2007, Pages 165-171

  Wu, F ^a   Zhou, L ^a   Chen, W R ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

Author keywords

Antitumour immunity; High intensity focused ultrasound; Immunotherapy; Neoplasm; Thermal ablation

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER RECURRENCE; CD4+ CD25+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FLOW CYTOMETRY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; METASTASIS POTENTIAL; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PROSTATE HYPERTROPHY; TREATMENT OUTCOME; TUMOR RESISTANCE; ANIMAL; ANTIBODY PRODUCTION; IMMUNITY; IMMUNOLOGY; METASTASIS; METHODOLOGY; NEOPLASM; REVIEW; TUMOR RECURRENCE; ULTRASOUND THERAPY;

ANIMALS; ANTIBODY FORMATION; HUMANS; IMMUNITY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; ULTRASONIC THERAPY;

EID: 33947098989     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701206638     Document Type: Article

References (52)

1. Hansbrough, JF, Bender, EM, Zapata-Sirvent, R. and Anderson, J. (1984) Altered helper and suppressor lymphocyte populations in surgical patients. Am J Surg, 148, pp. 303-307.
2. Mafune, K. and Tanaka, Y. (2000) Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. Ann Surg Oncol, 7, pp. 609-616.
3. Vallejo, R., Hord, ED, Barna, SA, Santiago-Palma, J. and Ahmed, S. (2003) Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol, 22, pp. 139-146.
4. van Sandick, JW, Gisbertz, SS, Berge, IJ ten, Boermeester, MA, Kraan, TC van der Pouw, Out, TA, Obertop, H. and van Lanschot, JJ (2003) Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg, 237, pp. 35-43.
5. Chamberlain, SM, Short, JH and Nias, AH (1980) Recovery of lymphocyte status after radiotherapy. Clin Radiol, 31, pp. 427-432.
6. Rotstein, S., Blomgren, H., Petrini, B., Wasserman, J. and Baral, E. (1985) Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys, 11, pp. 921-925.
7. Shukla, HS, Hughes, LE, Whitehead, RH and Newcombe, RG (1986) Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: A 10 year study. Cancer Immunol Immunother, 21, pp. 6-11.
8. Toivanen, A., Granberg, I. and Nordman, E. (1984) Lymphocyte subpopulations in patients with breast cancer after postoperative radiotherapy. Cancer, 54, pp. 2919-2923.
9. van Rijswijk, RE, Sybesma, JP and Kater, L. (1984) A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease. Cancer, 53, pp. 62-69.
10. Dodd III, GD, Soulen, MC, Kane, RA, Livraghi, T., Lees, WR, Yamashita, Y., Gillams, AR, Karahan, OI and Rhim, H. (2000) Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough. Radiographics, 20, pp. 9-27.
11. Goldberg, SN, Gazelle, GS and Mueller, PR (2000) Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol, 174, pp. 323-331.
12. Gazelle, GS, Goldberg, SN, Solbiati, L. and Livraghi, T. (2000) Tumor ablation with radiofrequency energy. Radiology, 217, pp. 633-646.
13. Kennedy, JE (2005) High intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer, 5, pp. 321-327.
14. (2006) Extracorporeal high intensity focused ultrasound in the treatment of solid malignancies. Minim Invasive Ther Allied Tech, 15, pp. 26-35.
15. Bayjoo, P., Rees, RC, Goepel, JR and Jacob, G. (1991) Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model. J Clin Lab Immunol, 35, pp. 129-132.
16. Miya, K., Saji, S., Morita, T., Niwa, H. and Sakata, K. (1987) Experimental study on mechanism of absorption of cryonecrotized tumor antigens. Cryobiology, 24, pp. 135-139.
17. Muller, LCH, Michsche, M., Yamagata, S. and Kerschbaumer, F. (1985) Therapeutic effect of cryosurgery of murine osteosarcoma-Influence on disease outcome and immune function. Cryobiology, 22, pp. 77-85.
18. Hansler, J., Neureiter, D.,Strobel, D., Muller, W., Mutter, D., Bernatik, T., Hahn, EG and Becker, D. (2002) Cellular and vascular reactions in the liver to radio-frequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs. Eur Surg Res, 34, pp. 357-363.
19. Wissniowski, TT, Hunsler, J., Neureiter, D.,Frieser, M., Schaber, S., Esslinger, B., Voll, R., Strobel, D., Hahn, EG and Schuppan, D. (2003) Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res, 63, pp. 6496-6500.
20. Brok, MH den, Sutmuller, RP, van der Voort, R., Bennink, EJ, Figdor, CG, Ruers, TJ and Adema, GJ (2004) In situ tumor ablation creates an antigen source for the generation of anti-tumor immunity. Cancer Res, 64, pp. 4024-4029.
21. Hill, CR, Rivens, I., Vaughan, M. and Haar, GR ter (1994) Lesion development in focused ultrasound surgery: A general model. Ultrasound Med Biol, 20, pp. 259-269.
22. Vaughan, M., Haar, G ter, Hill, CR, Clarke, RL and Hopewell, JW (1994) Minimally invasive cancer surgery using focused ultrasound: A pre-clinical, normal tissue study. Br J Radiol, 67, pp. 267-274.
23. Chen, WZ, Bai, J., Zou, JZ, Wang, ZL, Zhu, H. and Wang, ZB (2001) Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol, 27, pp. 1099-1106.
24. Clement, GT (2004) Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics, 42, pp. 1087-1093.
25. Chen, WZ, Bai, J., Zou, JZ, Wang, ZL, Zhu, H. and Wang, ZB (2002) Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol, 28, pp. 535-542.
26. Delon-Martin, C., Vogt, C., Chignier, E., Guers, C., Chapelon, JY and Cathignol, D. (1995) Venous thrombosis generation by means of high-intensity focused ultrasound. Ultrasound Med Biol, 21, pp. 113-119.
27. Rivens, IH, Rowland, IJ, Denbow, M., Fisk, NM, Haar, GR ter and Leach, MO (1999) Vascular occlusion using focused ultrasound surgery for use in fetal medicine. Eur J Ultrasound, 9, pp. 89-97.
28. Hynynen, K., Chung, A., Colucci, V. and Jolesz, FA (1996) Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo. Ultrasound Med Biol, 22, pp. 193-201.
29. Vaezy, S., Martin, R., Kaczkowski, P., Keilman, G.,Goldman, B.,Yaziji, H., Carter, S., Caps, M. and Crum, L. (1999) Use of high-intensity focused ultrasound to control bleeding. J Vasc Surg, 29, pp. 533-542.
30. Kennedy, JE, Haar, GR ter, Gleeson, FV, Roberts, IS, Middleton, MR and Cranston, D. (2004) Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasound. Ultrasound Med Biol, 30, pp. 851-854.
31. Van Leenders, GJLH, Beerlage, HP, Ruijter, ET, de la Rosette, JJMCH and van de Kaa, CA (2000) Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol, 53, pp. 391-394.
32. Wang, ZB, Cao, YD, Chen, WZ, Zou, JZ, Bai, J., Zhu, H., Li, KQ, Jin, CB and Xie, FL (2003) Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound. Ultrasound Med Biol, 29, pp. 1487-1492.
33. Wang, ZB, Cao, YD, Xu, ZL, Zhou, Q., Zhu, H. and Chen, WZ (2006) Heat fixation of cancer cells ablated with high intensity focused ultrasound in patients with breast cancer. Am J Surg, 192, pp. 179-184.
34. Wang, ZB, Cao, YD, Zhou, Q., Zhang, Y. and Zhu, XQ (2007) Expression of tumor antigens and heat shock protein 70 in breast cancer cells after high intensity focused ultrasound ablation. Ann Surg Oncol
35. Chen, WR, Zhu, W-G, Dynlacht, JR, Liu, H. and Nordquist, RE (1999) Long-term tumor resistance induced by laser photo-immunotherapy. Int J Cancer, 81, pp. 808-812.
36. Chen, WR, Singhal, AK, Liu, H. and Nordquist, RE (2001) Laser immunotherapy induced antitumor immunity and its adoptive transfer. Can Res, 61, pp. 459-461.
37. Chen, WR, Ritchey, JW, Bartels, KE, Liu, H. and Nordquist, RE (2002) Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Can Res, 62, pp. 4295-4299.
38. Chen, WR, Jeong, SW, Lucroy, MD, Wolf, RF, Howard, EW, Liu, H. and Nordquist, RE (2003) Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach. Int J Cancer, 107, pp. 1053-1057.
39. Yang, R., Reilly, CR, Rescorla, FJ, Sanghvi, NT, Fry, FJ, Franklin, TD and Grosfeld, JL (1992) Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma. J Pediatr Surg, 27, pp. 246-251.
40. Yang, XY, Liu, Y., Morse, MA, Lyerly, HK, Clay, TM and Zhong, P. (2005) Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun, 335, pp. 124-131.
41. Rosberger, DF, Coleman, DJ, Silverman, R., Woods, S., Rondeau, M. and Cunningham-Rundles, S. (1994) Immunomodulation in choroidal melanoma: Reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther, 5, pp. 59-68.
42. Wang, X. and Sun, J. (2002) High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl), 115, pp. 1332-1335.
43. Wang, ZB, Xu, ZL, Chen, WZ, Zhu, H. and Jin, CB (2004) Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol, 30, pp. 1217-1222.
44. Madersbacher, S., Grobl, M., Kramer, G., Dirnhofer, S., Steiner, GE and Marberger, M. (1998) Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate, 37, pp. 174-181.
45. Kramer, G., Steiner, GE, Grobl, M., Hrachowitz, K., Reithmayr, F., Paucz, L., Newman, M., Madersbacher, S., Gruber, D. and Susani, M. (2004) Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate, 58, pp. 109-120.
46. Wang, ZB, Cao, YD, Chen, WZ, Zou, JZ, Bai, J. and Zhu, H. (2003) A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer, 89, pp. 2227-2233.
47. Lepock, JR, Frey, HE and Ritchie, KP (1993) Protein denaturation in intact hepatocytes and isolated cellular organelles during heat shock. J Cell Biol, 122, pp. 1267-1276.
48. Pockley, AG (2003) Heat shock proteins as regulators of the immune response. Lancet, 362, pp. 469-476.
49. Todryk, SM, Michael, J., Goughy, MJ and Pockley, AG (2003) Facets of heat shock protein 70 show immunotherapeutic potential. Immunology, 110, pp. 1-9.
50. Menoret, A Antoine and Srivastava, P. (2002) Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol, 14, pp. 45-51.
51. Lewis, JJ (2004) Therapeutic cancer vaccines: Using unique antigens. PNAS, 101, pp. 14653-14656.
52. Schueller, G., Kettenbach, J., Sedivy, R., Bergmeister, H., Stift, A., Fried, J., Gnant, M. and Lammer, J. (2004) Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model. Oncol Reports, 12, pp. 495-499.